Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
摘要:
We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADPribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1 and 1A2 was identified as a metabolic concern, and strategies to improve pharmacokinetic properties are reported. These efforts culminated in the identification of 2-{4-[(3S)-piperidin-3yl]phenyl}-2H-indazole-7-carboxamide 56 (MK-4827), which displays good pharmacokinetic properties and is currently in phase I clinical trials. This compound displays excellent PARP 1 and 2 inhibition with IC50 = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibited PARP activity with EC50 = 4 nM and inhibited proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10-100 nM range. Compound 56 was well tolerated in vivo and demonstrated efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer.
New route to pyrido[1,2-b]pyridazinium inner salts. Evidence of a 1,3-dipolar cycloaddition-ring expansion process
作者:Jesús Valenciano、Ana M. Cuadro、Juan J. Vaquero、Julio Alvarez-Builla
DOI:10.1016/s0040-4039(98)02406-x
日期:1999.1
reacted with Michael acceptors, giving rise to the corresponding cycloadducts which, depending on their regioisomeric nature, subsequently undergo a ring expansion to give pyrido[1,2-b]pyridazinium inner salts.
2-烷氧羰基吡啶鎓N-氨基化物与迈克尔受体反应时表现为1,3-偶极子,产生相应的环加合物,取决于其区域异构体性质,随后进行环扩环,使吡啶并[1,2- b ]吡啶鎓内部盐。
2-Alkoxycarbonylpyridinium N-Aminides: 1,3-Dipoles or 1,4-Nucleophile−Electrophile Synthons? Experimental and Theoretical Evidence for the Mechanism of Pyrido[1,2-<i>b</i>]pyridazinium Inner Salt Formation
作者:Jesús Valenciano、Ana M. Cuadro、Juan J. Vaquero、Julio Alvarez-Builla、Raul Palmeiro、Obis Castaño
DOI:10.1021/jo9909655
日期:1999.12.1
2-Alkoxycarbonylpyridinium N-aminides behave as 1,3-dipoles toward acetylenic compounds and as 1,4-nucleophile-electrophiles with heterocumulenes in a [4 + 2] cyclocondensation process, yielding in the latter case conjugated mesomeric betaines. These N-aminides also behave as 1,3-dipoles when reacted with olefinic dipolarophiles, producing the corresponding cycloadducts that, depending on their regioisomeric nature, subsequently undergo a ring expansion process to produce pyrido[1,2-b]-pyridazinium inner salts. A mechanistic investigation performed using both PM3 frontier molecular orbital (FMO) and potential energy surface (PES) analysis at the RHF/6-31+G* level indicates that both the cycloaddition reaction and the ring expansion occur in a concerted way rather than through a stepwise mechanism via a zwitterionic intermediate.
Discovery of 2-{4-[(3<i>S</i>)-Piperidin-3-yl]phenyl}-2<i>H</i>-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as poly(ADPribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to improve enzyme and cellular activity, and the resulting PARP inhibitors display antiproliferation activities against BRCA-1 and BRCA-2 deficient cancer cells, with high selectivity over BRCA proficient cells. Extrahepatic oxidation by CYP450 1A1 and 1A2 was identified as a metabolic concern, and strategies to improve pharmacokinetic properties are reported. These efforts culminated in the identification of 2-4-[(3S)-piperidin-3yl]phenyl}-2H-indazole-7-carboxamide 56 (MK-4827), which displays good pharmacokinetic properties and is currently in phase I clinical trials. This compound displays excellent PARP 1 and 2 inhibition with IC50 = 3.8 and 2.1 nM, respectively, and in a whole cell assay, it inhibited PARP activity with EC50 = 4 nM and inhibited proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10-100 nM range. Compound 56 was well tolerated in vivo and demonstrated efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer.
2-Alkoxycarbonylcycloimmonium ylides, efficient 1,4-dipole equivalents in the synthesis of new conjugated betaines.
作者:Ana M. Cuadro、Jesús Valenciano、Juan J. Vaquero、José L. García Navío、Julio Alvarez-Builla
DOI:10.1016/s0040-4020(01)89900-2
日期:1993.4
Several heterocyclic mesomeric betaines containing the bicyclic systems pyridol[1,2-a]pyrazine and pyrido [2,1-f][1,2,4]triazine have been prepared by reaction of 2-alkoxycarbonyl pyridinium N-ylides with phenyl isocyanate and isothiocyanate.